Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. The company is headquartered in Niagara Falls, New York. The firm specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.
POSC stock price ended at $1.5 on 水曜日, after dropping 7.98%
On the latest trading day Jan 21, 2026, the stock price of POSC fell by 7.98%, dropping from $1.60 to $1.50. During the session, the stock saw a volatility of 6.67%, with prices oscillating between a daily low of $1.50 and a high of $1.60. On the latest trading day, the trading volume for POSC decreased by 2.6K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 713 shares were traded, with a market value of approximately $47.1M.